Abstract 15586: Burden of Cardiovascular or Fatal Outcomes in People With Type 2 Diabetes and Cardiovascular Risk Factors Treated With Dulaglutide a Post Hoc Analysis From the Rewind Trial

Authors: Gilles Dagenais, Mark C Lakshmanan, Leanne Dyal, Charles Messan Atisso, Helen Colhoun, Lars E Ryden, Hertzel C Gerstein

Published: 2021-05-10

DOI: 10.1161/circ.142.suppl_3.15586

Source: Full article


Abstract

Introduction: